Slump in medtech VC activity continues
By Nick Paul Taylor VC investments in medtech startups increased once the initial shock of the pandemic passed. From the third quarter of...
top of page
Other Languages
Recognized by Forbes
Top 150
America's Best Executive Recruiting Firms.
Search
Orthopedic markets to return to normal this year as post-pandemic boost fades
By Nick Paul Taylor Orthopedic companies have made a fast start to 2023, with Zimmer Biomet’s CEO saying “pretty much everything went...
Medical device companies are in an ‘emerging bull market,’ Jim Cramer says
by Julie Coleman CNBC’s Jim Cramer on Monday touted the burgeoning bull market of medical devices, noting positive earnings reports from...
Med-tech financings April 2023
by BioWorld Venture capital comprises 86% of declining med-tech financings in April Med-tech financings have continued to decline from...
Maximizing M&A Value: Avoiding Common Mistakes by Sellers
WRITTEN BY MEDWORLD ADVISORS As veteran medtech industry executives, we’ve worked on various types of deals throughout our careers,...
Medtech’s top R&D spenders and the projects they launched
By Medical Design & Outsourcing Each company spent more than 15% of their revenue on research. These 10 medtech companies have spent the...
Don't Let the Ghost of Spine Deals Past Spook Future Deals
Amanda Pedersen Globus Medical and NuVasive have caused quite the stir in the spine market since announcing merger plans a few weeks...
Medtech CDMO sector poised for M&A rebound in 2023 amid ‘attractive’ targets: report
By Nick Paul Taylor While the number of M&A transactions in the sector last year fell to 46 from 52 in 2021, breaking up deal activity...
Medtech earnings highlights: Easing of macro pressures, accelerated growth in 2023
By MEDTECHDIVE Medical device companies spent the final three months of 2022 facing many of the same challenges that curbed growth...
Medtech M&A outlook for 2023: Spinoffs, China exits, AI opportunities poised to spur deal rebound
By MEDTECHDIVE Companies flush with cash are looking for good investments and innovative products that can reduce procedure costs,...
Artificial intelligence could save healthcare industry $360B a year
By HEALTHCAREDIVE Dive Brief: Artificial intelligence could save the U.S. up to $360 billion annually if adopted more widely in...
9 Key Investor Milestones Every Med Device Developer Should Know
By MED DEVICE ONLINE Let’s face it. Designing, developing, and bringing a medical device to market takes money — lots of it. While true...
Digital health outlook: trends to watch in 2023
By Medical Device Network Big data and AI attracted attention in 2022, but recession concerns and reimbursement uncertainty may continue...
Medtech companies start 2023 on ‘optimistic’ note amid earnings forecasts, staffing: J.P. Morgan
By MEDTECHDIVE Executive comments at the healthcare conference in San Francisco suggests companies expect staffing pressures and supply...
‘Mixed signals’ from medtech management suggest industry had bumpy end to 2022: analysts
By MEDTECHDIVE Dive Brief: Medtech management teams have given “mixed signals” in the year’s first set of company presentations, leading...
PitchBook Analyst Note: Takeaways From the 2023 J.P. Morgan Healthcare Conference:
Deals, Trends, and Predictions By PitchBook Taking the pulse of healthcare's premier conference Healthcare’s premier industry event...
How Companies Can Thrive in Today’s Medtech Environment
By Medical Device and Diagnostic Industry PwC’s Future of Medtech Report offers three business models to consider when operating in the...
North America’s medical devices industry saw a drop of 38.60% in deal activity during November 2022
By Medical Device Network North America’s medical devices industry saw a drop of 38.60% in deal activity during November 2022, when...
The biggest medtech stock gainers, losers in 2022
By MASS DEVICE In another roller coaster year for medtech, these are the companies that saw their stock rise and fall the most...
A look back at medtech’s top 10 acquisitions of 2022
By MEDTECHDIVE While larger acquisitions were announced at the end of the year including J&J’s $16.6B purchase of Abiomed, the number of...
bottom of page